In last trading session, iBio Inc (NASDAQ:IBIO) saw 0.67 million shares changing hands with its beta currently measuring 0.95. Company’s recent per share price level of $0.80 trading at $0.07 or 9.82% at ring of the bell on the day assigns it a market valuation of $13.21M. That closing price of IBIO’s stock is at a discount of -761.25% from its 52-week high price of $6.89 and is indicating a premium of 20.0% from its 52-week low price of $0.64. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.21 million shares which gives us an average trading volume of 1.25 million if we extend that period to 3-months.
For iBio Inc (IBIO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
iBio Inc (NASDAQ:IBIO) trade information
Upright in the green during last session for gaining 9.82%, in the last five days IBIO remained trading in the green while hitting it’s week-highest on Wednesday, 05/14/25 when the stock touched $0.80 price level, adding 2.28% to its value on the day. iBio Inc’s shares saw a change of -67.37% in year-to-date performance and have moved 3.39% in past 5-day. iBio Inc (NASDAQ:IBIO) showed a performance of -18.41% in past 30-days. Number of shares sold short was 1.73 million shares which calculate 0.88 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 3.6 to the stock, which implies a rise of 77.78% to its current value. Analysts have been projecting 3.6 as a low price target for the stock while placing it at a high target of 3.6. It follows that stock’s current price would drop -350.0% in reaching the projected high whereas dropping to the targeted low would mean a loss of -350.0% for stock’s current value.
iBio Inc (IBIO) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 57.55% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 59.06% while estimates for its earnings growth in next 5 years are of 45.01%.
iBio Inc (NASDAQ:IBIO)’s Major holders
Insiders are in possession of 4.31% of company’s total shares while institution are holding 15.78 percent of that, with stock having share float percentage of 16.49%. Investors also watch the number of corporate investors in a company very closely, which is 15.78% institutions for iBio Inc that are currently holding shares of the company.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 73.14 shares of worth $58479.0 or 0.44% of the total outstanding shares. The later fund manager was in possession of 54.73 shares on Mar 31, 2025 , making its stake of worth around $43753.0 in the company or a holder of 0.33% of company’s stock.
